About the investment
Established in 1995, Deltamune plays a trusted role in veterinary and public health, by developing and manufacturing vaccines used in production animals for the food market – particularly poultry. More recently, the company has expanded its vaccination range to address the ruminant market (cattle, sheep etc.).
Phatisa is aligned with the United Nations Development Programme (UNDP) Sustainable Development Goals (SDGs). All our portfolio companies are evaluated for their contribution to these goals. This portfolio company has the following impacts: